![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Pharma Blog Watch
Pharma Blog Watch
Caraco
Wins on a Ratio (Patent Docs)
In his post, Donald Zuhn discusses a recent patent suit between Ortho-McNeil
and Caraco Pharmaceutical over Ortho's patent for Ultracet (tramadol HCl/acetaminophen).
The patent covers formulations containing the active ingredients in a certain
ratio. Caraco had filed an abbreviated new drug application (ANDA) for a generic
version of the drug.
"The threshold issue in this case involves the proper construction of the term 'about 1:5.' Before the District Court, Ortho argued that 'about 1:5' means 'approximately 1:5, and encompasses a range of ratios of at least 1:3.6 to 1:7.1,' and Caraco countered that the term means 'approximately 1:5, subject perhaps to minor measuring errors of, say, 5 or 10 percent'," he writes. "Based on its construction of the term 'about 1:5,' the District Court concluded that the composition described in Caraco's ANDA did not literally infringe [on] the '691 patent."
KEYWORDS Drug Pipeline Alert
Upcoming Events
-
11Jul
-
18Jul
-
21Oct